Related content

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer

By Shi Yi-kang   Li Zhong-hua   Han Xi-qian   Yi Ji-hu   Wang Zhen-hua   Hou Jing-li   Feng Cong-ran   Fang Qing-hong   Wang Hui-hui   Zhang Peng-fei   Wang Feng-shan   Shen Jie   Wang Peng  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1131-1140

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells

By    

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1238-1244

Spandidos Publications

Access to resources Recommend Favorite

Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling

By            

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3249-3256

Spandidos Publications

Access to resources Recommend Favorite

Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells

By Shiragami Risa   Murata Soichiro   Kosugi Chihiro   Tezuka Tohru   Yamazaki Masato   Hirano Atsushi   Yoshimura Yukino   Suzuki Masato   Shuto Kiyohiko   Koda Keiji  

International Journal of Oncology, Vol. 43, Iss. 2, 2013-08 ,pp. : 431-438

Spandidos Publications

Access to resources Recommend Favorite

Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells

By Ong Pei-Shi   Wang Xin-Qiao   Lin Hai-Shu   Chan Sui-Yung   Ho Paul C.  

International Journal of Oncology, Vol. 40, Iss. 5, 2012-05 ,pp. : 1705-1713

Spandidos Publications

Access to resources Recommend Favorite